Oramed Pharmaceuticals Inc. share price logo

Oramed Pharmaceuticals Inc.

NASDAQ: ORMP

Small Cap

$4.79

+0.16

(+3.34%)

as on

Oramed Pharmaceuticals Inc. Stock Performance

as on July 1, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.60
    $4.86
    downward going graph

    3.97%

    Downside

    1.46%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.98
    $5.19
    downward going graph

    58.77%

    Downside

    8.35%

    Upside

    downward going graph

Oramed Pharmaceuticals Inc. share price movements today

Previous Close
$4.64
Open
$4.70
Volume
474.9K
Day's Low - High
$4.60 - $4.86
52 Week Low - High
$1.98 - $5.19

Oramed Pharmaceuticals Inc. Historical Returns

1 Month Return
+ 16.88 %
3 Month Return
+ 41.46 %
1 Year Return
+ 106.22 %
3 Year Return
+ 29.61 %
5 Year Return
-65.32 %

Oramed Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Oramed Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$191.1M

EPS (TTM)

2.31

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.41%

PE Ratio (TTM)

1.8

Industry PE ratio

-3.6310633484162897

PEG Ratio

0

EBITDA

-14.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

58.16%

Oramed Pharmaceuticals Inc. Stock Valuation

Track how Oramed Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.

Oramed Pharmaceuticals Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-25.81x)

November 30, 2021

Industry (-3.63x)

June 30, 2026

Today (1.80x)

June 30, 2026

Highest (16.43x)

November 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 1.80x

Oramed Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oramed Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
HOLD$191.1M-65.32%1.80.00%NA
BUY$38.7B506.87%NA0.00%NA
BUY$38.9B73.15%73.0312.55%NA
BUY$124.7B147.81%29.1635.51%NA
BUY$66.4B13.12%15.4629.65%0.58%

Stock Returns calculator for Oramed Pharmaceuticals Inc. Stock including INR - Dollar returns

The Oramed Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Oramed Pharmaceuticals Inc. investment value today

Current value as on today

₹2,35,147

Returns

₹1,35,147

(+135.15%)

Returns from Oramed Pharmaceuticals Inc. Stock

₹1,12,889 (+112.89%)

Dollar Impact

₹22,258 (+22.26%)

Analyst Recommendation on Oramed Pharmaceuticals Inc. Stock

Based on 7 analysts

HOLD

0.00%

Buy

57.14%

Hold

42.86%

Sell

Based on 7 analysts, 57.14% of analysts recommend a 'HOLD' rating for Oramed Pharmaceuticals Inc.. Average target price of $6.25

Oramed Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Oramed Pharmaceuticals Inc..

What analysts predicted

23.36%UPSIDE

Target Price

$6.25

Current Price

$4.79

Analyzed by

7 Analysts

Target

$6.25

Oramed Pharmaceuticals Inc. target price $6.25, a slight upside of 23.36% compared to current price of $4.79. According to 7 analysts rating.

Indian Investors' Interest in Oramed Pharmaceuticals Inc. Stock

Search interest for Oramed Pharmaceuticals Inc. Stock has increased by 233% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:233% versus previous 30 day period

Oramed Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Feb 2024
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
2
-
-
-
-
Gross Profit
-
0
0
0
0
0
0
0
0
0
Operating Income
-
-2
-3
-3
-3
-4
-2
-2
-5
-3
EBITDA
-
2
11
-3
-9
-4
13
59
9
-3
Interest Expense
-
0
0
15
15
2
-
-
0
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-
1
10
-18
-9
-7
13
59
9
49
Income Tax Expense
-
-
1
1
0
0
0
11
0
11
Net Income
1
1
9
-19
-10
-7
13
48
10
38
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-382.10%
0.00%
0.00%
0.00%
0.00%

Oramed Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Aug 2020
Dec 2020
Aug 2021
Dec 2021
Aug 2022
Dec 2022
Aug 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
2
2
2
2
2
2
1
-
2
Gross Profit
-
2
-
2
-
2
-
1
0
0
Operating Income
-
-11
-
-24
-
-40
-
-15
-12
-15
EBITDA
-
-11
-
-25
-
-36
-
7
-14
75
Interest Expense
-
-
-
0
-
2
-
3
0
-
Depreciation
-
0
-
0
-
0
-
0
0
0
Income Before Tax
-
-11
-
-22
-
-37
-
5
-15
75
Income Tax Expense
-
0
-
-2
-
0
-
-
3
11
Net Income
-11
-11
-22
-22
-36
-37
-37
5
-19
64
Net Profit Margin
-424.76%
-424.76%
-822.72%
-822.72%
-1352.61%
-1397.11%
-1397.11%
412.31%
0.00%
3202.50%

Oramed Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
1
9
-19
-10
-7
13
48
10
38
Operating Cash Flow
-1
2
-7
-1
-3
-3
-1
0
-2
Investing Cash Flow
29
93
-33
15
23
-55
38
-1
-19
Financing Cash Flow
-19
-30
-1
-1
-
0
0
-4
-10
Change in Cash
9
66
-42
12
20
-58
36
-6
-32

Oramed Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-10
-12
-14
-11
-22
-36
5
-19
64
Operating Cash Flow
-5
-14
-12
-12
-21
-28
-10
-8
-9
Investing Cash Flow
4
-7
11
4
-22
30
-73
105
5
Financing Cash Flow
1
22
-
23
101
11
51
-52
-4
Change in Cash
0
1
-1
15
57
-36
-31
45
-8

Global Institutional Holdings in Oramed Pharmaceuticals Inc.

Funds
Holdings
Jane Street Group LLC
0.13%
Hillsdale Investment Management Inc.
0.24%
BlackRock Inc
0.23%
Royal Bank of Canada
0.12%
Mercer Global Advisors Inc.
4.67%

Insights on Oramed Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 10.00M → 38.31M (in $), with an average increase of 73.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ORMP stock has moved up by 11.3%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 666.0K → 2.0M (in $), with an average increase of 22.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 620.1% return, outperforming this stock by 590.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 423.6% return, outperforming this stock by 317.4%

About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
OrganisationOramed Pharmaceuticals Inc.
Headquarters1185 Avenue of the Americas, New York, NY, United States, 10036
IndustryBiotechnology
CEOMr. Nadav Kidron Esq.
E-voting on sharesClick here to vote

Key Management of Oramed Pharmaceuticals Inc.

Name

Title

Mr. Nadav Kidron Esq.

President, CEO & Executive Chairman

Mr. Joshua Hexter

Chief Operating & Business Officer

Dr. Miriam Kidron Ph.D.

Chief Scientific Officer & Director

Mr. Avraham Gabay

CFO, Treasurer & Secretary

FAQs

What is Oramed Pharmaceuticals Inc. share price today?

Oramed Pharmaceuticals Inc. share price today is $4.79 as on at the close of the market. Oramed Pharmaceuticals Inc. share today touched a day high of $4.86 and a low of $4.6.

What is the 52 week high and 52 week low for Oramed Pharmaceuticals Inc. share?

Oramed Pharmaceuticals Inc. share touched a 52 week high of $5.19 on and a 52 week low of $1.98 on . Oramed Pharmaceuticals Inc. stock price today i.e. is closed at $4.79,which is 7.71% down from its 52 week high and 142.53% up from its 52 week low.

What is Oramed Pharmaceuticals Inc.'s market capitalisation today?

Oramed Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in Oramed Pharmaceuticals Inc. Stock (ORMP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Oramed Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oramed Pharmaceuticals Inc. Shares that will get you 0.3132 shares as per Oramed Pharmaceuticals Inc. share price of $4.79 per share as on July 1, 2026 at 1:29 am IST.

What is the minimum amount required to buy Oramed Pharmaceuticals Inc. Stock (ORMP) from India?

Indian investors can start investing in Oramed Pharmaceuticals Inc. (ORMP) shares with as little as ₹94.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.60 in Oramed Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Oramed Pharmaceuticals Inc. share’s latest price of $4.79 as on July 1, 2026 at 1:29 am IST, you will get 2.0877 shares of Oramed Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that Oramed Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

Oramed Pharmaceuticals Inc. stock has given -65.32% share price returns and 27.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?